Noram Plans Next Phase of Exploration in the Clayton Valley and at Arizaro East, Argentina

Noram Ventures Inc. (TSXV:NRM / Frankfurt:N7R / OTCBB:NRVTF) (“Noram” or the “Company”) is pleased to provide an update on its exploration plans for the 2700 hectare lithium exploration project in the Salar de Arizaro, Salta, Argentina and for a Phase III drill program in Clayton Valley, Nevada. Clayton Valley, Nevada On November 21, 2017, the […]

Teck: Quebrada Blanca Phase 2 Receives Regulatory Approval

Teck Resources (TSX:TECK.A,TSX:TECK.B,NYSE:TECK) has announced that it has received regulatory approval for its Quebrada Blanca phase 2 project (QB2) in the Tarapacá Region in northern Chile. According to Teck’s release, the regional environmental committee of Tarapacá has voted to approve the project environmental impact assessment. Receipt of the environmental qualification resolution is expected in the […]

Phase 1 Exploration Program Commences at Buena Vista Hills Cobalt Project, Pershing County, Nevada

New Tech Lithium Corp (CSE:NTM) is pleased to announce that it has initiated a Phase 1 exploration program at its Buena Vista Hills Cobalt project, located 25 miles southeast of Lovelock, Nevada. The program, with an estimated budget of US $ 250,000, will consist of a review and re-interpretation of a historic airborne magnetic survey, a […]

Phase Two of Ethereum (ETH) is Coming Soon, Says Joe Lubin

Ethereum phase two: Co-founder of Ethereum (ETH), Joseph Lubin, just made a big announcement about the world’s second largest blockchain ecosystem. He spoke at the Rise conference yesterday in Hong Kong and revealed that the first layer of the Ethereum ecosystem is now complete and phase two should be finalized sometime this year. Lubin states that […]

Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia

Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, today announced that the Company has received approval from the Spanish Agency for Medicinal Products and Medical Devices (AEMPS), to initiate its Phase 2, double-blind, placebo-controlled 14-week trial of the safety and efficacy of ANAVEX®2-73 for […]